1、Deng J, Sun D, Luo F, Zhang Q, Chen F, Xu J, Zhang Z.Anti-IFN-γ Antibody Promotes Osteoclastogenesis in Human Bone Marrow Monocyte-Derived Macrophages Co-Cultured with Tuberculosis-Activated Th1 Cells. Cell Physiol Biochem. 2018; 49(4):1512-1522 .

2、Sun D, Luo F, Xing JC, Zhang F, Xu JZ, Zhang ZH .1,25(OH)2D3 inhibited Th17 cells differentiation via regulating the NF‐κB activity and expression of IL‐17. Cell Prolif. 2018;51(5):e12461.

3、Wu W, Lyu J, Liu X, Luo F, Hou T, Zhou Q, Li Z, Chen Y, Li LT, Zheng Y, Wang G, Xu J, Zhang Z.Surgical Treatment of Thoracic Spinal Tuberculosis: A Multicenter Retrospective Study. World Neurosurg. 2018;110:e842-e850.

4、Zhang Z， Luo F, Zhou Q, Dai F, Sun D, Xu J.The outcomes of chemotherapy only treatment on mild spinal tuberculosis. J Orthop Surg Res,2016, 11(1):49.

5、Zhang Z， Dai F, Cheng P, Luo F, Hou T, Zhou Q, Xie Z, Deng M, Xu JZ. Pitavastatin attenuates monocyte activation in response to orthopedic implant-derived wear particles by suppressing the NF-κB signaling pathway. Mol Med Rep, 2015 ,12(5):6932-6938.

6、Zhang Z， Dai F, Luo F, Zhong M, Huang Z, Hou T, Xu J. Could high concentration rifampicin kill rifampicin-resistant M.tuberculosis Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis. J Orthop Surg Res, 2014, 9:124.

7、Zhang Z， Wang X, Luo F, Yang H, Hou T, Zhou Q, Dai F, He Q, Xu J.Effects of rifampicin on osteogenic differentiation and proliferation of human mesenchymal stem cells in the bone marrow. Genet Mol Res, 2014.13(3):6398-6410.

8、Zhang Z，Li L, Luo F, Cheng P, Wu F, Wu Z, Hou T, Zhong M, Xu J. Rapid and accurate detection of RMP-and INH-resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio DNA microarray:A prospective validation study. BMC INFECT DIS, 2012;12:303.

9、Yang HF, Zhang Z（共一），Xiang LB, Tang KL, Luo F, Liu CY, Zhou JB, Li JQ, Xu JZ. 25（OH）D3 Affects the Maturation and Function of Mouse Bone Marrow-Derived Dendritic Cells Stimulated by Mycobacterium Bovis BCG. PLOS ONE, 2012;7(11):e48062.

10、Li L, Xu J, Ma Y, Tang D, Chen Y, Luo F, Li D, Hou T, Zhou Q, Dai F, He Q, Zhang Z. Surgical Strategy and Management Outcomes for Adjacent Multisegmental Spinal Tuberculosis: A Retrospective Study of Forty-eight Patients. Spine, 2014.39（1）：40-48.

11、Li JH,Zhang ZH（共同通讯）, Shi T, Dai F, Zhou Q, Luo F, Hou TY, He QY, Deng MY, Xu JZ. Surgical treatment of lumbosacral tuberculosisby one-stage debridement and anterior instrumentation with allograft through an extraperitoneal anterior approach. J Orthop Surg Res 2015, 10:62.

12、Yang HF,Zhang ZH（共一）, Chang ZQ, Tang KL, Lin DZ, Xu JZ. Vitamin D deficiency affects the immunity against Mycobacterium tuberculosis infection in mice. Clin Exp Med 2012, 13(4):265-270.

13、Li L, Zhang ZH（共一）, Luo F, Xu J, Cheng P, Wu Z, Zhou Q, He Q, Dai F, Wang J, Zhang J. Management of Drug-resistant Spinal Tuberculosis with a Combination of Surgery and Individualized Chemotherapy:A Retrospective Analysis of 35 Patients. International Orthopaedics 2012, 36(2):277–283.

14、张泽华,陈非凡,李建华,罗飞,代飞,侯天勇,周强,何清义,许建中. 不同类型腰骶椎结核手术治疗方式的有效性和安全性研究。 中华骨科杂志, 2016,36(11): 662-671.

15、张泽华，李建华，黄学全，代飞，罗飞，周强，何清义，张劲松，陈永林，许建中。CT引导下置管引流局部强化化疗治疗结核性腰大肌脓肿和椎旁脓肿.脊柱外科杂志.2014.12（6）：326-330.

16、张泽华，张帅，罗飞，王嘉嘉，谢肇，马树枝，许建中，王序全。同种异体骨植骨联合锁定加压钢板治疗四肢良性骨肿瘤及类瘤病变的随访研究.第三军医大学学报，2014，36（11）：1213-1216.

17、张泽华，罗飞，吴铮，程鹏，许建中.基因芯片早期诊断脊柱结核耐药。中华检验医学杂志.2010，33（11）：1090-1093.

18、张泽华，侯天勇，梅铁牛。以病例为中心教学法在八年制骨科见习中的应用.局解手术学杂志.2013.22（6）: 676-677

19、张泽华，罗飞，吴铮。骨科实习教学中的实践操作训练.局解手术学杂志.2012.21（1）:100-101.

20、李建华,陈非凡,罗飞,代飞 ,侯天勇,周强,何清义,许建中,张泽华。49例耐药脊柱结核的耐药表型及个体化治疗的回顾性分析. 中华骨科杂志, 2016,36(11): 699-708.

21、《脊柱外科聚焦》，第22章，脊柱结核，人民军医出版社，2007

22、《骨科学研究生教材》第2版第7章，脊柱结核 ，人民卫生出版社，2014

23、《脊柱畸形精要》第14章，神经肌源性脊柱侧凸,上海科学技术出版社，2009

24、《早发性脊柱侧凸》第18章，世界图书出版公司,2016

脊柱结核脓液穿刺置管引流工具， （专利号：ZL201320058091.5)（排名第4）2013年

生物蛋白胶复合于富孔隙生物材料的负压灌注装置， （专利号：ZL201320058080.7)（排名第2）2013年

螺钉可多向锁定固定装置， （专利号：201020518107.2)（排名第5）2010年

手动细胞富集装置， （专利号：201020518067.1)（排名第1）2010年